Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
199 Leser
Artikel bewerten:
(0)

Nancy Greengold, M.D., Named Vice President of Clinical Integration at Huntington Memorial Hospital

PASADENA, Calif., Aug. 21, 2013 /PRNewswire-USNewswire/ --Nancy Greengold, M.D., MBA, has been appointed to the newly created position of vice president of clinical integration at Huntington Memorial Hospital, effective immediately. In her new role and consistent with Huntington's core mission and business strategies, Dr. Greengold is responsible for helping to drive operational excellence in all of the hospital's clinical areas.

(Photo: http://photos.prnewswire.com/prnh/20130821/DC67842)

"All of healthcare is in the midst of a very challenging time, and Dr. Greengold will play a critical role in making sure that we continue to enhance the quality of care we provide while we look at new ways to deliver exceptional, affordable care to our community," said Paula Verrette, M.D., senior vice president of quality and physician services. "Dr. Greengold will take the lead in proposing new care models and in developing new initiatives in chronic disease management with the goal of improving quality, enhancing the patient experience and decreasing cost."

Dr. Verrette says that the implementation of the Affordable Care Act and other environmental changes necessitates hospitals to "evolve care delivery models, which include new methods designed to manage health populations within our community." Toward that end, she says that Dr. Greengold is tasked with helping to promote care integration and effective practice management across independent physicians and will serve as the clinical lead for the operations of the Huntington accountable care organization (ACO).

Dr. Greengold comes to Huntington Hospital from Cedars-Sinai Medical Care Foundation where she served as the medical lead for clinical efficiencies. Immediately prior she was president of Zynx Health Device Network and before that vice president and chief medical officer of Hearst Business Media. Dr. Greengold earned her medical degree at George Washington University School of Medicine in Washington, D.C. and her MBA (with a focus study in healthcare) from the University of California at Irvine.

Huntington Memorial Hospital is a 625-bed not-for-profit hospitalthat is home to the only Level II trauma center inthe San Gabriel Valley. In addition to being granted Magnet® status in 2011, Huntington Hospital has been ranked nationally by U.S. News and World Report in two specialties and was named the eighth best hospital in California. Renowned for its programs in neurosciences, cardiovascular services and cancer care, Huntington Hospital is an activeteaching hospital withgraduate medical education programs in internal medicine and general surgery. Consistent with its mission the hospital provides millions of dollars annually in charity care, benefits for vulnerable populations, health research, education and training, and support programs that may otherwise be absent from the community. For more information, visit www.huntingtonhospital.com.

SOURCE Huntington Memorial Hospital

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.